Welcome : Guest

SOFT TISSUE ALLOGRAFTS - A GLOBAL STRATEGIC BUSINESS REPORT   

Research Abstract

This report analyzes the worldwide markets for Soft Tissue Allografts in US$ Million by the following segments: Cartilage Allografts, Meniscus Allografts, and Tendon Allografts. The report provides separate comprehensive analytics for the US, Japan, Europe, Asia-Pacific and Rest of World. Annual estimates and forecasts are provided for each region for the period 2006 through 2015. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain. The report profiles 66 companies including many key and niche players such as -

AlloSource
Conmed Corp.
Cook Medical, Inc.
Covidien Public Limited Company
Genzyme Corp.
LifeCell Corp.

Click here to request a full list of companies covered in the report...

Code: MCP-6333
Price: $3950
Companies: 66
Pages: 399
Date: August 2010
Market Data Tables: 167
 



TABLE OF CONTENTS


  SOFT TISSUE ALLOGRAFTS (Complete Report) Pages : 399   | $3950

   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Quantitative Techniques & Analytics.....I-3
Product Definitions and Scope of Study.....I-3
  
   Orthopedics Products Market – A Prelude.....II-1 1$100
   Table 1: Worldwide Orthopedic Products Market (2008): Percentage Share Breakdown of Revenue by Product Segment (includes corresponding Graph/Chart).....II-2

Table 2: Worldwide Orthopedic Products Market (2008): Percentage Share Breakdown of Revenue by Leading Players (includes corresponding Graph/Chart).....II-2
A Review of Soft Tissue Repair/Arthroscopy Market.....II-2
1$300
   Key Facts.....II-3
Table 3: Soft Tissue Disorders - Percentage Breakdown by Age Group (includes corresponding Graph/Chart).....II-3
1$300
   Allografts – A Preface.....II-4
Advanced Allografts Encroaching into the Use of Autografts in Surgical
  Procedures.....II-4
Soft Tissue Allografts - Current and Future Analysis.....II-4
1$100
   Tendon Allograft Constitutes for a Larger Share, While Meniscus Grows Faster.....II-5
Hernia Repair – A Peek into the Critical Soft Tissue Repair Procedural Area.....II-5
Hernia Repair Devices Market to Witness Robust Growth.....II-5
Tension Free Hernia Repair Techniques Score Over Tension Technique.....II-5
1$100
   Competitive Scenario.....II-6
Hernia Repair Devices Market Lures New Players & Inspires Innovation.....II-6
Table 4: Leading Players in the Global Hernia Repair Devices Market (2009): Percentage Breakdown of Value Sales for Davol, Ethicon, Covidien, LifeCell, Gore, Synovis, and Others (includes corresponding Graph/Chart).....II-6
1$300
   Market Statistics.....II-7
Table 5: World Recent Past, Current and Future Analysis for Hernia Repair Devices by Geographic Region - US and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart).....II-7
1$300
   Table 6: World Recent Past, Current and Future Analysis for Biologic Meshes by Geographic Region - US and Rest of World Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart).....II-81$300
   Table 7: World Recent Past, Current and Future Analysis for Synthetic Meshes by Geographic Region - US and Rest of World Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart).....II-91$300
   Soft Tissue: An Introduction.....II-10
Soft Tissue Injuries.....II-10
Soft Tissue Allografts.....II-10
Cartilage.....II-10
1$100
   Classification.....II-11
Hyaline Cartilage.....II-11
Elastic Cartilage.....II-11
Fibrocartilage.....II-11
Diseases and Treatment Procedures.....II-11
Osteoarthritis.....II-11
1$100
   Traumatic Rupture.....II-12
Achondroplasia.....II-12
Costochondritis.....II-12
Spinal Disc Herniation.....II-12
Relapsing Polychondritis.....II-12
Tumors.....II-12
Meniscus.....II-12
1$100
   Meniscus Tear.....II-13
Symptoms.....II-13
Diagnosis.....II-13
Treatment.....II-13
1$100
   Tendons.....II-14
Tendon Injuries.....II-14
Select Treatment Procedures.....II-14
Arthroscopy: A Keyhole Surgery.....II-14
Arthroscopy - A Review.....II-14
1$100
   How Arthroscopy is performed?.....II-15
Complications.....II-15
Multi-Electrode Procedure.....II-15
Electrothermal Arthroscopy.....II-15
1$100
   Cartilage Repair: An Overview of Available Treatment Procedures.....II-16
Growth Factors for Cartilage, Dental, Tendon and Bone Repair.....II-16
Resorbables: An Emerging Technology.....II-16
1$100
   Injectable Biodegradable Polymers for Repair and Augmentation of Soft Tissues.....II-17
Soft Tissue Repair – Key Procedural Areas.....II-17
Hernia – A Review.....II-17
Types of Abdominal Hernia.....II-17
1$100
   Inguinal Hernia.....II-18
Indirect Inguinal Hernia.....II-18
Direct Inguinal Hernia.....II-18
Ventral Hernia.....II-18
Femoral Hernia.....II-18
Umbilical Hernia.....II-18
Diaphragmatic Hernia.....II-18
Causes.....II-18
1$100
   Symptoms.....II-19
Hernia Repair.....II-19
Types of Hernia Repair.....II-19
Tension Repair.....II-19
Tension-free Open Repair.....II-19
Laparoscopic Tension-free Repair.....II-19
1$100
   Hernia Repair Devices.....II-20
Hernia Trusses.....II-20
Mesh.....II-20
Knee Prosthesis.....II-20
1$100
   Smith & Nephew Launches DYONICS RF System.....II-21
CONMED Launches Matryx™ Biocomposite Interference Screw in New Sizes.....II-21
1$100
   Ethicon Launches GYNECARE PROLIFT+M™ Pelvic Floor Repair System.....II-22
TEI Biosciences Introduces SurgiMend® PRS.....II-22
TEI Biosciences Rolls Out SurgiMend® 2.0, 3.0, and 4.0.....II-22
Biomerix Receives US FDA Approval for REVIVE.....II-22
1$100
   Serica Technologies Secures US FDA Approval for SeriScaffold Technology.....II-23
ReGen Biologics Receives US FDA Approval for Menaflex.....II-23
Core Essence Orthopaedics Receives Regulatory Approval for SECURUS.....II-23
Insightra Medical Introduces Freedom Ventral.....II-23
1$100
   Covidien Launches DuraSeal™.....II-24
Covidien Introduces Devices for Minimally Invasive Surgery and Soft Tissue
  Repair.....II-24
Synovis Life Technologies Receives CE Approval for Veritas Collagen Matrix.....II-24
1$100
   Genzyme to Introduce Three Products in India.....II-25
Covidien Launches SILS™ PORT.....II-25
Covidien Introduces Novel Hernia Repair Mesh.....II-25
Covidien Unveils Permacol Biologic Implant.....II-25
1$100
   Wright Medical Launches BioTape XM Reinforcement Matrix.....II-26
CorMatrix Cardiovascular Receives FDA Approval for CorMatrix ECM™.....II-26
1$100
   Covidien Rolls Out AbsorbaTack 5mm Hernia Fixation Tool in Europe.....II-27
Orthomimetics Receives CE Mark Approval for Chondromimetic Implant.....II-27
Cook Medical Unveils Next Generation Biodesign™ Technology.....II-27
Brennen Medical Introduces XenMatriX.....II-27
1$100
   W. L. Gore & Associates Introduces GORE BIO-A Tissue Reinforcement.....II-28
LifeCell Corp. Secures FDA Approval for Strattice™ Tissue Matrix.....II-28
Atrium Medical Secures FDA Approval for C-QURLite™ Mesh.....II-28
1$100
   TEI Biosciences Introduces SurgiMend™ Collagen Matrix.....II-291$100
   Cook Medical Bags Major Soft-Tissue Repair Contract.....II-30
RTI Biologics Inks Agreement with Davol.....II-30
TEI Biosciences and MedPort, LLC Ink Agreement.....II-30
Biomet Takes Over Cartilix.....II-30
1$100
   Synovis Life Technologies Acquires Pegasus Biologics.....II-31
Davol Acquires XenMatrix.....II-31
TiGenix Acquires Orthomimetics.....II-31
Regrow Establishes Stem Cell Laboratory in Lonavala.....II-31
1$100
   Cook Medical Inks an Agreement with Premier Purchasing.....II-32
Kensey Nash to Re-acquire Distribution Rights for OsseoFit.....II-32
Tornier Enters into Partnership with T.A.G Medical Products.....II-32
Synovis Divests Interventional Business.....II-32
1$100
   USHIFU Takes Over Focus Surgery.....II-33
Regeneration Technologies Merges with Tutogen Medical.....II-33
Pegasus Biologics to Expand Facilities.....II-33
Adept Technology Collaborates with Prosurgics to Develop Surgical Robots.....II-33
1$100
   Orteq Bioengineering Receives Funding to Back Actifit™ Launch.....II-34
AngioDynamics Pockets Oncobionic.....II-34
Kinetic Concepts Takes-Over LifeCell.....II-34
Covidien Buys Scandius BioMedical.....II-34
1$100
   MiMedx Acquires SpineMedica.....II-35
Pioneer Surgical Technologies Purchases Encelle.....II-35
Biomet Inks Agreement with Kensey Nash.....II-35
2$125
   AlloSource (USA).....II-37
Conmed Corp. (USA).....II-37
Cook Medical, Inc. (USA).....II-37
1$100
   Covidien Public Limited Company (Ireland).....II-38
Genzyme Corp. (USA).....II-38
LifeCell Corp. (USA).....II-38
Lifelink Tissue Bank (USA).....II-38
1$100
   LifeNet Health (USA).....II-39
RTI Biologics, Inc. (USA).....II-39
TEI Bioscience, Inc. (USA).....II-39
1$100
   W. L. Gore & Associates, Inc. (USA).....II-40
Zimmer, Inc. (USA).....II-40
Market Participants in Soft Tissue Repair Market.....II-40
Arthrex, Inc. (USA).....II-40
B. Braun Melsungen AG (Germany).....II-40
1$100
   Aesculap Ag & Co. (Germany).....II-41
Biosyntech, Inc. (Canada).....II-41
Davol, Inc. (USA).....II-41
DePuy, Inc. (USA).....II-41
1$100
   Ethicon, Inc. (USA).....II-42
Smith & Nephew, Inc. (USA).....II-42
Stryker Orthopaedics (USA).....II-42
Synovis Surgical Innovations (USA).....II-42
1$100
   United States Surgical Corp. (USA).....II-431$100
   Table 8: World Recent Past, Current & Future Analysis for Soft Tissue Allografts Market by Geographic Region - US, Japan, Europe, Asia-Pacific and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart).....II-441$300
   Table 9: World 10-Year Perspective for Soft Tissue Allografts Market by Geographic Region - Percentage Breakdown of Dollar Sales for US, Japan, Europe, Asia-Pacific and Rest of World Markets for Years 2006, 2010, and 2015 (includes corresponding Graph/Chart).....II-451$300
   Table 10: World Recent Past, Current & Future Analysis for Soft Tissue Allografts Market by Product Segment - Cartilage Allografts, Meniscus Allografts, and Tendon Allografts Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart).....II-461$300
   Table 11: World 10-Year Perspective for Soft Tissue Allografts by Product Segment - Percentage Breakdown of Dollar Sales for Cartilage Allografts, Meniscus Allografts, and Tendon Allografts Markets for Years 2006, 2010, and 2015 (includes corresponding Graph/Chart).....II-471$300
   A. Market Analysis.....III-1
Current and Future Analysis.....III-1
FDA Vindication Boosts Orthopedic Soft Tissue Allograft Market.....III-1
US Soft Tissue Repair Market: An Outlook.....III-1
1$75
   Table 12: US Soft Tissue Repair Market (2008): Percentage Share Breakdown of Revenues for Inguinal Hernia Repair, Ventral Hernia Repair, Vaginal Sling, Pelvic Floor Reconstruction, and Others (includes corresponding Graph/Chart).....III-2

Table 13: US Cartilage Repair Market (2008): Percentage Share Breakdown of Revenues for Knee Cartilage Repair, Knee Joint Replacement and Others (includes corresponding Graph/Chart).....III-2
Laparoscopic Surgery Drives Hernia Repair Market.....III-2
Table 14: US Hernia Repair Market (2008): Percentage Share Breakdown of Treatment Procedures for Inguinal Hernia, Ventral Hernia and Others (includes corresponding Graph/Chart).....III-2
1$150
   US Ventral Hernia Repair Market.....III-3
Orthopedic Soft Tissue Repair Market.....III-3
1$75
   Soft Tissue Repair Devices Market.....III-4
US – The Largest Market for Hernia Repair Devices.....III-4
Biologic Meshes Gaining Ground.....III-4
Synthetic Meshes Apt for Inguinal Hernia Repairs.....III-4
Market Analysis.....III-4
1$75
   Table 15: US Recent Past, Current & Future Analysis for Hernia Repair Devices by Product Segment - Biologic Meshes and Synthetic Meshes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart).....III-51$150
   Table 16: US 10-Year Perspective for Hernia Repair Devices by Product Segment - Percentage Breakdown of Dollar Sales for Biologic Meshes and Synthetic Meshes Markets for Years 2006, 2009 & 2015 (includes corresponding Graph/Chart).....III-6
Competitive Dynamics.....III-6
Hernia Repair: A Highly Consolidated Market.....III-6
1$150
   Key Findings.....III-7
Table 17: Leading Players in the US Hernia Repair Market (2008): Percentage Share Breakdown of Revenues for Davol (BCR), US Surgical, Ethicon Endosurgery, LifeCell and Others (includes corresponding Graph/Chart).....III-7
Leading Players in the US Hernia Market (2008) by Tissue Type.....III-7
Table 18: Leading Players in the US Hernia Synthetic Meshes Market (2009): Percentage Breakdown of Value Sales for C.R. Bard, Ethicon, Covidien, and Others (includes corresponding Graph/Chart).....III-7
1$150
   Table 19: Leading Players in the US Hernia Biologics Products Market (2009): Percentage Breakdown of Value Sales for LifeCell, Cook Medical, Covidien, C.R. Bard, Synovis, and Others (includes corresponding Graph/Chart).....III-8

Table 20: Leading Players in the US Hernia Fixation Product Market (2009): Percentage Breakdown of Value Sales for C.R. Bard, Ethicon, Covidien, and Others (includes corresponding Graph/Chart).....III-8

Table 21: US Ventral Hernia Market (2008): Percentage Breakdown of No. of Procedures and Value Sales for Complicated Hernias and Routine Hernias (includes corresponding Graph/Chart).....III-8
1$150
   Table 22: Leading Players in the US Complicated Ventral Hernia Market (2008): Percentage Breakdown of Value Sales for LifeCell, C.R. Bard, Covidien, Cook Medical, and Others (includes corresponding Graph/Chart).....III-9

Table 23: Leading Players in the US Routine Ventral Hernia Market (2008): Percentage Breakdown of Value Sales for C.R. Bard, Ethicon, and Gore (includes corresponding Graph/Chart).....III-9
1$150
   Cartilage Repair Market.....III-10
Leading Players in the US Cartilage Repai Market (2007).....III-10
Product Approvals/Launches.....III-10
7$175
   Strategic Corporate Developments.....III-174$150
   Key Players.....III-216$175
   B. Market Analytics.....III-27
Table 24: US Recent Past, Current & Future Analysis for Soft Tissue Allografts - Annual Sales Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart).....III-27
1$150
   A. Market Analysis.....III-28
Current and Future Analysis.....III-28
B. Market Analytics.....III-28
Table 25: Japanese Recent Past, Current & Future Analysis for Soft Tissue Allografts - Annual Sales Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart).....III-28
1$150
   A. Market Analysis.....III-29
Current and Future Analysis.....III-29
European Soft Tissue Repair Devices Market – A Preview.....III-29
Hernia Repair Market: An Overview.....III-29
Demand Soars for Soft Tissue Meshes in Europe.....III-29
Product Approvals/Launches.....III-29
2$100
   Strategic Corporate Developments.....III-311$75
   Key Players.....III-321$75
   B. Market Analytics.....III-33
Table 26: European Recent Past, Current & Future Analysis for Soft Tissue Allografts - Annual Sales Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart).....III-33
1$150
   A. Market Analysis.....III-34
Current and Future Analysis.....III-34
Product Approvals/Launches.....III-34
Strategic Corporate Developments.....III-34
1$75
   B. Market Analytics.....III-35
Table 27: Asia-Pacific Recent Past, Current & Future Analysis for Soft Tissue Allografts - Annual Sales Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart).....III-35
1$150
   A. Market Analysis.....III-36
Current and Future Analysis.....III-36
Review of Select Markets.....III-36
Canada.....III-36
Hernia Repair Market: Increasing Adoption of Premium Priced Meshes to Drive
  Growth.....III-36
Latin America.....III-36
An Overview of the Hernia Repair Market.....III-36
1$75
   Premium Priced Hernia Repair Devices Market: Increased Adoption of Laparoscopy to
  Drive Growth.....III-37
Biosyntech, Inc. – A Key Canadian Player.....III-37
1$75
   B. Market Analytics.....III-38
Table 28: Rest of World Recent Past, Current & Future Analysis for Soft Tissue Allografts - Annual Sales Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart).....III-38
1$150
  
Total Companies Profiled: 64 (including Divisions/Subsidiaries - 71)

Region/Country Players

The United States 56 Europe 12 Germany 3 The United Kingdom 4 Italy 1 Rest of Europe 4 Asia-Pacific (Excluding Japan) 2 Middle East 1
Click here to request a full table of contents and more details on this project.